By Disease

Oncology

CODE TEST METHOD TAT PREFERRED SAMPLE TYPE
MGM070 Lymphoproliferative disorder gene panel NGS 6 WEEKS Bone marrow / tissue / EDTA blood / DNA
MGM167 Lynch Syndrome 4 gene (MLH1,MLH2, MSH6 & PMS2) panel NGS 4 WEEKS Peripheral Blood / Purified Genomic DNA
MGM168 ALL risk stratification gene panel – B-ALL NGS 3 WEEKS Peripheral Blood / Bone Marrow / Purified Genomic DNA
MGM169 ALL risk stratification gene panel – T-ALL NGS 3 WEEKS Peripheral Blood / Bone Marrow / Purified Genomic DNA
MGM170 AML risk stratification gene panel NGS 3 WEEKS Peripheral Blood / Bone Marrow / Purified Genomic DNA
MGM171 APC gene analysis NGS 3 WEEKS Peripheral Blood / Purified Genomic DNA
MGM172 APC gene analysis Sanger 3 WEEKS Peripheral Blood / Purified Genomic DNA
MGM173 BCR-ABL qualitative gene fusion analysis Qualitative
RT-PCR+
5 DAYS Peripheral Blood
MGM174 BCR-ABL quantitative (International Scale) gene fusion analysis RT-PCR+ 7 DAYS Peripheral Blood
MGM175 BCR-ABL quantitative gene fusion analysis RT-PCR+ 7 DAYS Peripheral Blood
MGM176 BRAF gene analysis – 2 exons (11 & 15) Sanger+ 7 DAYS Fresh frozen tissue/FFPE blocks/Glass slides
MGM177 BRAF V600E mutation analysis RT-PCR 7 DAYS Fresh frozen tissue/FFPE blocks/Glass slides
MGM178 BRCA1 & BRCA2 deletion/duplication analysis MLPA 3 WEEKS Peripheral Blood / Purified Genomic DNA
MGM179 BRCA1 & BRCA2 gene analysis NGS 3 WEEKS Peripheral Blood / Purified Genomic DNA
MGM180 BRCA1 & BRCA2 gene analysis Sanger+ 6 WEEKS Peripheral Blood / Purified Genomic DNA
MGM181 BRCA1 gene analysis Sanger+ 3 WEEKS Peripheral Blood / Purified Genomic DNA
MGM182 BRCA2 gene analysis Sanger+ 3 WEEKS Peripheral Blood / Purified Genomic DNA
MGM183 Carney complex (PRKAR1A) gene analysis NGS 4 WEEKS Peripheral Blood / Purified Genomic DNA
MGM184 Chronic myeloproliferative disorder gene panel (CMPD) NGS 3 WEEKS Peripheral Blood / Bone Marrow/ Purified Genomic DNA
MGM185 CLL prognostication/risk stratification gene panel NGS 3 WEEKS Peripheral Blood / Bone Marrow/ Purified Genomic DNA
MGM186 CML/CNL (atypical) – prognostication gene panel NGS 3 WEEKS Peripheral Blood / Bone Marrow/ Purified Genomic DNA
MGM187 Comprehensive cancer gene panel (germline) NGS 6 WEEKS Peripheral Blood / Purified Genomic DNA
MGM188 EFT/PNET Fusion Transcript Analysis RT-PCR 10 DAYS Fresh frozen tissue/FFPE blocks/Glass slides
MGM189 EGFR gene analysis – 4 exons (18, 19, 20, 21) Sanger+ 10 DAYS Fresh frozen tissue/FFPE blocks
MGM190 EGFR gene analysis (Hot Spot) RT-PCR+ 7 DAYS Fresh frozen tissue/FFPE blocks
MGM191 Familial MDS-AML gene panel NGS 3 WEEKS Peripheral Blood / Bone Marrow/ Purified Genomic DNA
MGM192 Familial MDS-AML gene panel-reflex MLPA 3 WEEKS Peripheral Blood / Bone Marrow/ Purified Genomic DNA
MGM193 FLT3 gene internal tandem duplication analysis and D835 point mutation analysis Fragment
analysis
& Sanger
2 WEEKS Bone Marrow/ Purified Genomic DNA
MGM194 Hereditary cancer gene panel NGS 6 WEEKS Peripheral Blood / Purified Genomic DNA
MGM195 HNPCC gene panel NGS 4 WEEKS Peripheral Blood / Purified Genomic DNA
MGM196 Somatic cancer mutation – Hot spot tumor panel NGS 4 WEEKS Fresh frozen tissue/FFPE blocks & Peripheral Blood in 2 Streck Tubes
MGM197 IDH1 gene analysis Sanger+ 7 DAYS Peripheral Blood; Fresh frozen tissue/FFPE blocks
MGM198 Imatinib Resistance (ABL kinase) gene analysis Sanger+ 10 DAYS Peripheral Blood
MGM199 JAK2 gene analysis – 2 exons (12, 14) Sanger+ 7 DAYS Peripheral Blood / Bone Marrow/ Purified Genomic DNA
MGM200 JMML risk stratification gene panel NGS 3 WEEKS Peripheral Blood / Bone Marrow/ Purified Genomic DNA
MGM201 KIT gene analysis – 2 exons (9,11) Sanger+ 7 DAYS Fresh frozen tissue/FFPE blocks
MGM202 KIT gene analysis – 4 exons (9, 11, 13, 17) Sanger+ 10 DAYS Fresh frozen tissue/FFPE blocks
MGM203 KRAS gene analysis (Hot Spot) NGS 7 DAYS Fresh frozen tissue/FFPE blocks
MGM204 KRAS gene analysis – 2 exons (2 & 3) Sanger+ 7 DAYS Fresh frozen tissue/FFPE blocks
MGM205 LCH/hairy cell leukemia – BRAF V600E
mutation analysis
NGS 3 WEEKS Peripheral Blood / Bone Marrow
MGM206 MDS prognostication and risk stratification gene panel NGS 3 WEEKS Peripheral Blood / Bone Marrow
MGM207 MGMT gene methylation analysis RT-PCR 2 WEEKS Fresh frozen tissue/FFPE blocks
MGM208 MPN – CALR (exon 9) gene analysis Fragment
analysis
7 DAYS Peripheral Blood / Bone Marrow
MGM209 MPN – JAK2 V617F mutation analysis Sanger+ 7 DAYS Peripheral Blood / Bone Marrow
MGM210 MPN – MPL (exon 10) gene analysis Sanger 7 DAYS Peripheral Blood / Bone Marrow
MGM211 MPN prognostication and risk stratification gene panel NGS 3 WEEKS Peripheral Blood / Bone Marrow
MGM212 NF1 deletion/duplication analysis MLPA+ 3 WEEKS Peripheral Blood / Purified Genomic DNA
MGM213 NF1 gene sequencing NGS 4 WEEKS Peripheral Blood / Purified Genomic DNA
MGM214 NF2 deletion/duplication analysis MLPA+ 3 WEEKS Peripheral Blood / Purified Genomic DNA
MGM215 NF2 gene sequencing NGS 4 WEEKS Peripheral Blood / Purified Genomic DNA
MGM216 NPM1 gene analysis (Hot Spot – exon 12) Fragment
analysis
2 WEEKS Peripheral Blood / Bone Marrow
MGM217 NRAS gene analysis (Hot Spot) RT-PCR 7 DAYS Fresh frozen tissue / FFPE blocks
MGM218 PDGFRA gene analysis – 3 exons (12, 14, 18) Sanger+ 10 DAYS Peripheral blood/Bone marrow/Fresh frozen tissue /
FFPE blocks
MGM219 PML-RARa gene fusion analysis Qualitative
RT-PCR+
10 DAYS Peripheral Blood / Bone Marrow
MGM220 PTEN gene analysis Sanger 3 WEEKS Peripheral Blood / Purified Genomic DNA
MGM221 RB1 gene analysis NGS 4 WEEKS Peripheral Blood / Purified Genomic DNA
MGM222 RB1 gene deletion/duplication analysis MLPA+ 3WEEKS Peripheral Blood / Purified Genomic DNA
MGM223 RET oncogene – 2 exons (10, 11) Sanger+ 10 DAYS Peripheral Blood / Purified Genomic DNA
MGM224 RET oncogene – 8 exons (5, 8, 10, 11, 13, 14, 15, 16) Sanger+ 6 WEEKS Peripheral Blood / Purified Genomic DNA
MGM225 ROS1 gene fusion analysis RT-PCR 2 WEEKS Fresh frozen tissue / FFPE blocks
MGM226 STK11 gene analysis Sanger 3 WEEKS Peripheral Blood / Purified Genomic DNA
MGM227 TP53 gene analysis NGS 4 WEEKS Peripheral Blood / Purified Genomic DNA
MGM228 TP53 gene analysis Sanger+ 3 WEEKS Peripheral Blood / Purified Genomic DNA
MGM235 VHL gene analysis Sanger+ 10 DAYS Peripheral Blood / Purified Genomic DNA
IMMUNOHISTOCHEMISTRY
MGM236 ALK D5F3 IHC 4 DAYS Fresh frozen tissue/FFPE blocks
MGM237 BRAF V600E IHC analysis IHC 4 DAYS Fresh frozen tissue/FFPE blocks blocks
MGM238 c-MET IHC analysis IHC 4 DAYS Fresh frozen tissue/FFPE blocks
MGM239 Prognostic/predictive IHC1 panel (ANY ONE OF – ER, PR, Her2/neu, MIB-1/Ki67) IHC 4 DAYS Fresh frozen tissue/FFPE blocks
MGM240 Prognostic/predictive IHC2 panel (ER, PR): IHC 4 DAYS Fresh frozen tissue/FFPE blocks
MGM241 Prognostic/predictive IHC3 panel (ER, PR, Her2/neu): IHC 4 DAYS Fresh frozen tissue/FFPE blocks
MGM242 Prognostic/predictive IHC4 panel (ER, PR, Her2/neu, MIB-1/Ki67) IHC 4 DAYS Fresh frozen tissue/FFPE blocks
MGM243 ROS1 IHC analysis IHC 4 DAYS Fresh frozen tissue/FFPE blocks

GENETIC TEST SELECTION LIST:

NGS : Next-Generation Sequencing, Sanger : Sanger Sequencing, MLPA : Multiplex Ligation-dependent Probe Amplification, RT-PCR : Real-Time PCR, IHC : Immunohistochemistry

Click on the link below to know about Sample Requirement

SAMPLE REQUIREMENT

Sitemap